At a glance
ClinicalIndex Comparison RecordN/ACompleted· 79 enrolled
Drug / intervention
Photochemotherapyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Skin Disease and Pulmonary Mortality After Transplantation
In Brief
An observational study evaluating Photochemotherapy for Pulmonary Mortality and Acute GVH Disease. Completed, enrolled 79 participants.
Detailed Summary
Predictors for pulmonary mortality was determined in a cohort of 79 patients with acute-GVHD of the skin. The acute-GVHD treatment was corticosteroids and photochemotherapy (Photosensitization with oral 8-methoxysalen and Ultraviolet light type A) with or without concomitant methotrexate.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Mortality, Acute GVH Disease
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartOct 2016
Primary CompletionNov 2016
First PostedOct 2017
TodayJul 2026
First PostedOct 25, 2017
Enrollment StartOct 21, 2016
Primary CompletionNov 24, 2016
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 8.7 years ago
Interventions
Photochemotherapyother
Retrospective evaluation of treatment outcome and risk for pulmonary mortality and relapse incidence